SWM
BSX icon

Shelton Wealth Management’s Boston Scientific BSX Stock Holding History

Shelton Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,144
Closed -$260K – 149
2026
Q1 		$260K Sell
4,144
-8,237
-67% -$659K 0.11% 116
2025
Q4 		$1.18M Buy
+12,381
New +$1.21M 0.51% 68
2025
Q2 		– Sell
-10,013
Closed -$1.01M – 150
2025
Q1 		$1.01M Sell
10,013
-1,271
-11% -$128K 0.55% 58
2024
Q4 		$1.01M Buy
11,284
+2,457
+28% +$216K 0.52% 68
2024
Q3 		$740K Buy
8,827
+998
+13% +$78.7K 0.4% 84
2024
Q2 		$603K Buy
7,829
+655
+9% +$47.9K 0.34% 86
2024
Q1 		$491K Buy
+7,174
New +$461K 0.31% 80

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Shelton Wealth Management's BSX Position: Q2 2026 in Review

Shelton Wealth Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,144 shares — an estimated $260K sold.

Shelton Wealth Management first reported a position in BSX in Q1 2024 and held it in 7 quarters. The position peaked at $1.18M in Q4 2025. 209 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Shelton Wealth Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Shelton Wealth Management sold 4,144 Boston Scientific shares in Q2 2026, an estimated $260K.
  • Shelton Wealth Management first reported a position in Boston Scientific in Q1 2024 and held it in 7 quarters.
  • Shelton Wealth Management's Boston Scientific position peaked at $1.18M in Q4 2025.
  • 209 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Shelton Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.